宫颈炎康栓治疗中重度宫颈炎的疗效观察
|
摘要
目的探讨宫颈炎康栓治疗宫颈炎妇科疾病的临床效果。方法选取2016年4月—2017年12月来本院治疗的96例宫颈炎患者作为研究对象,按照随机数表法分为两组。对照组48例微波治疗仪(DWYIV型)进行治疗,观察组48例对照组的基础上采用宫颈炎康栓治疗,10d为1疗程,连续治疗2个疗程。比较两组患者的临床治疗效果。结果观察组的治疗总有效率为97.92%,对照组为83.33%,差异具有统计学意义(P <0.05)。结论宫颈炎康栓治疗宫颈炎疾病患者的临床效果显著。
Objective To investigate the clinical effect of cervicitis kangchuan in treating gynecological diseases of cervicitis. Methods96 patients with cervicitis treated in our hospital from April 2016 to December 2017 were selected as the study subjects. They were divided into two groups according to the random number table method.48 cases in the control group was treated with microwave therapy instrument(DWY-IV). 48 cases in observation group, on the basis of control group, were treated with cervicitis suppository. The treatment lasted for 10 days and lasted for 2 courses. The clinical effects of the two groups were compared. Results The total effective rate was97.92% in the observation group and 83.33% in the control group, with statistical significance(P < 0.05). Conclusion Cervicitis kangchuan has remarkable clinical effect in treating patients with cervicitis disease and has clinical value.
Objective To investigate the clinical effect of cervicitis kangchuan in treating gynecological diseases of cervicitis. Methods96 patients with cervicitis treated in our hospital from April 2016 to December 2017 were selected as the study subjects. They were divided into two groups according to the random number table method.48 cases in the control group was treated with microwave therapy instrument(DWY-IV). 48 cases in observation group, on the basis of control group, were treated with cervicitis suppository. The treatment lasted for 10 days and lasted for 2 courses. The clinical effects of the two groups were compared. Results The total effective rate was97.92% in the observation group and 83.33% in the control group, with statistical significance(P < 0.05). Conclusion Cervicitis kangchuan has remarkable clinical effect in treating patients with cervicitis disease and has clinical value.
引文
[1]韩亚琴,张玲玲,代庆林,等.重组人干扰素α-2b栓联合保妇康栓治疗慢性宫颈炎合并高危型HPV感染的临床研究[J/OL].川北医学院学报,2019(3):422-424[2019-07-16].http://kns.cnki.net/kcms/detail/51.1254.R.20190628.0927.054.html.
[2]万秀玲.保妇康栓联合左氧氟沙星治疗宫颈炎的效果[J].中外女性健康研究,2019(10):50,82.
[3]胡慧娟,李春梅.保妇康栓对宫颈炎患者伴人乳头瘤病毒感染的临床疗效评价[J].抗感染药学,2019,16(3):506-508.
[4]贺岩.保妇康栓联合重组人干扰素α-2b凝胶治疗慢性宫颈炎伴高危型HPV感染效果观察[J].中国民康医学,2019,31(9):49-50.
[5]春花.宫颈炎康栓治疗宫颈糜烂的疗效价值分析[J].世界最新医学信息文摘(连续型电子期刊),2019,19(36):101,108.
[6]陈静.重组人干扰素α-2b凝胶联合保妇康栓对慢性宫颈炎患者血清VEGF、NKTs的影响[J].中国合理用药探索,2019,16(5):23-25,29.
[7]王萍.重组人干扰素α-2a栓联合保妇康栓对慢性宫颈炎合并HPV感染的疗效体会[J].实用妇科内分泌电子杂志,2019,6(12):104,106.
[8]张冬梅.保妇康栓联合激光治疗中老年慢性宫颈炎伴HPV感染患者临床分析[J].实用妇科内分泌电子杂志,2019,6(11):128,132.
[9]程丽.宫颈炎康栓联合左氧氟沙星治疗宫颈炎的效果观察[J].首都食品与医药,2019,26(8):74.
[10]王晓雨.保妇康栓联合重组人干扰素α2b阴道泡腾胶囊治疗慢性宫颈炎伴HPV感染的效果[J].中国民康医学,2019,31(7):126-127.
[11]唐福蒂.治糜康栓联合阿奇霉素治疗慢性宫颈炎的临床效果分析[J].实用妇科内分泌电子杂志,2019,6(10):92,95.
[12]刘敏.保妇康栓治疗宫颈炎合并HPV感染的临床分析[J].中外医学研究,2019,17(10):59-60.
[13]蒋红梅.保妇康栓治疗妊娠合并慢性宫颈炎的疗效分析[J].医学信息,2019,32(7):160-161.
[14]金强珍.康妇消炎栓联合保妇康栓治疗宫颈炎的效果研究[J].基层医学论坛,2019,23(11):1616-1617.
[15]高辉.保妇康栓治疗宫颈炎合并HPV感染的临床观察[J].中国医药指南,2019,17(4):168-169.
[2]万秀玲.保妇康栓联合左氧氟沙星治疗宫颈炎的效果[J].中外女性健康研究,2019(10):50,82.
[3]胡慧娟,李春梅.保妇康栓对宫颈炎患者伴人乳头瘤病毒感染的临床疗效评价[J].抗感染药学,2019,16(3):506-508.
[4]贺岩.保妇康栓联合重组人干扰素α-2b凝胶治疗慢性宫颈炎伴高危型HPV感染效果观察[J].中国民康医学,2019,31(9):49-50.
[5]春花.宫颈炎康栓治疗宫颈糜烂的疗效价值分析[J].世界最新医学信息文摘(连续型电子期刊),2019,19(36):101,108.
[6]陈静.重组人干扰素α-2b凝胶联合保妇康栓对慢性宫颈炎患者血清VEGF、NKTs的影响[J].中国合理用药探索,2019,16(5):23-25,29.
[7]王萍.重组人干扰素α-2a栓联合保妇康栓对慢性宫颈炎合并HPV感染的疗效体会[J].实用妇科内分泌电子杂志,2019,6(12):104,106.
[8]张冬梅.保妇康栓联合激光治疗中老年慢性宫颈炎伴HPV感染患者临床分析[J].实用妇科内分泌电子杂志,2019,6(11):128,132.
[9]程丽.宫颈炎康栓联合左氧氟沙星治疗宫颈炎的效果观察[J].首都食品与医药,2019,26(8):74.
[10]王晓雨.保妇康栓联合重组人干扰素α2b阴道泡腾胶囊治疗慢性宫颈炎伴HPV感染的效果[J].中国民康医学,2019,31(7):126-127.
[11]唐福蒂.治糜康栓联合阿奇霉素治疗慢性宫颈炎的临床效果分析[J].实用妇科内分泌电子杂志,2019,6(10):92,95.
[12]刘敏.保妇康栓治疗宫颈炎合并HPV感染的临床分析[J].中外医学研究,2019,17(10):59-60.
[13]蒋红梅.保妇康栓治疗妊娠合并慢性宫颈炎的疗效分析[J].医学信息,2019,32(7):160-161.
[14]金强珍.康妇消炎栓联合保妇康栓治疗宫颈炎的效果研究[J].基层医学论坛,2019,23(11):1616-1617.
[15]高辉.保妇康栓治疗宫颈炎合并HPV感染的临床观察[J].中国医药指南,2019,17(4):168-169.